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Evidence of sensitisation to the fungus Aspergillus fumigatus is common in patients with cystic fibrosis. We describe here three adult Figure I CT scan of thorax clearly demonstrating the presence of an aspergilloma in the right upper lobe ofpatient 1.
patients who developed pulmonary aspergillomas many years after becoming sensitised to A fumigatus, an association to our knowledge not previously described. All three patients had very poor lung function at the time of the diagnosis of an aspergilloma and two of the three patients have since died.
Case reports PATIENT 1 MB, a woman, was diagnosed with cystic fibrosis at 12 years of age by a positive sweat test. In 1968, at the age of 14, she presented with haemoptysis at which time sputum culture grew Staphylococcus aureus. Chest radiography showed nodular cystic changes consistent with cystic fibrosis. Contrast bronchography revealed proximal bronchiectasis in both upper lobes. She presented again in 1986 with wheeze, dyspnoea, purulent sputum, and pulmonary infiltrates. She had positive skin prick test to extracts of A fumigatus, peripheral eosinophilia, and sputum examination revealed fungal hyphae. The total IgE antibody titre was raised at 275 kU/l (0-120 kU/l), and tests for specific IgE antibodies to Afumigatus measured by the radioallergosorbent method (RAST) were positive as were serum IgG antibodies to A fumigatus detected by enzyme linked immunosorbent assay (ELISA). A diagnosis of allergic bronchopulmonary aspergillosis was made and she was commenced on inhaled and systemic steroids. In 1991 her respiratory status deteriorated and chest radiographs now revealed a newly acquired rounded 5 cm diameter lesion in the right upper lobe characteristic of an aspergilloma. A computed tomographic (CT) scan of the thorax confirmed the presence ofan aspergilloma in the right upper lobe (fig 1) to cystic fibrosis. This extends the spectrum of chronic fibrotic conditions which may predispose to aspergilloma formation, such as tuberculosis, sarcoidosis, pneumoconiosis, and ankylosing spondylitis.' It is surprising that such an association with cystic fibrosis has not been recorded previously. As many as 60% of patients with cystic fibrosis may have positive sputum cultures for fungi2 and precipitating antibodies to A fumigatus may be detected in 30% ofpatients.3 Furthermore, a firm diagnosis of the clinical-radiological syndrome of allergic bronchopulmonary aspergillosis has been observed in about 10% of patients with cystic fibrosis.4 Despite this, we have found no previous reports of pulmonary aspergilloma developing in this group of patients.
Cystic fibrosis is a condition in which secretion of abnormal mucus results in plugging of the distal airways leading to chronic pulmonary infection and destruction oflung tissue. The presence of necrotic tissue and lung cysts provides an ideal environment for the colonisation of the airways by A fumigatus and the development of related conditions such as allergic bronchopulmonary aspergillosis and aspergilloma. This colonisation may also be facilitated by the frequent use of both oral and inhaled corticosteroids which may be required to control symptoms in these patients, by the advent of diabetes mellitus, and by the associated poor nutritional status common to this disease.
The development of an aspergilloma represents an additional potential hazard for patients with cystic fibrosis. Although many patients may for a time remain unaffected by aspergilloma, there is clearly potential for developing severe haemoptysis which may require emergency measures such as bronchial artery embolisation. Furthermore, the presence of an aspergilloma may be a significant impediment for patients being considered for lung transplantation. The possibility of effective treatment is unfortunately limited. Patients with end stage cystic fibrosis are unlikely to be considered for surgical intervention. While the results of both intracavitary instillation and systemic treatment with antifungal agents has been disappointing,5 these measures may need to be evaluated for efficacy in the unique setting of cystic fibrosis.
In conclusion, as the median age of survival of patients with cystic fibrosis rises and with the increased use of CT scanning for clinical assessment, it is likely that the diagnosis of pulmonary aspergilloma will be made with greater frequency in adult patients with cystic fibrosis. 
